Business Context and Reporting Period
Boston Omaha Corporation (BOC), a Delaware corporation, filed this Form 8-K on September 10, 2026. The filing primarily addresses the Board of Directors' approval of a new share repurchase program and includes a Regulation FD disclosure regarding a press release issued on September 11, 2026.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or debt levels. The only financial data provided relates to capital allocation activities:
- New Authorization: Up to $30 million for the repurchase of Class A common stock.
- Prior Program Activity: As of September 10, 2026, the Company repurchased 1,607,323 shares under the 2025 plan for a total cost of approximately $21 million.
- Funding Source: Repurchases are intended to be financed using available cash and cash equivalents.
Material Changes
The material change disclosed is the authorization of a new $30 million share repurchase program effective November 1, 2026. This new program replaces the prior 2025 program, which was set to expire on December 31, 2026. The new program extends the repurchase authority through December 31, 2027, or until the $30 million limit is reached.
Guidance, Outlook, and Risks
Management indicated that repurchases will be made at the Company's discretion based on market conditions, share price, and share availability. The Company is not obligated to repurchase any specific number of shares. The Board retains the right to modify, suspend, extend, or terminate the program at any time. The filing explicitly states that the information provided shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the exact number of shares repurchased under the new program once activity commences on November 1, 2026.
- Confirm the Company's current cash and cash equivalents balance to assess the impact of the $30 million authorization on liquidity.
- Review the full text of the press release (Exhibit 99.1) for any additional qualitative commentary on capital allocation strategy.
- Monitor future filings for any suspension or termination of the program as permitted by the Board.